The Sciton Halo hybrid fractional laser allows physicians to apply tunable nonablative and ablative wavelengths in a single pass to maximize patient results and reduce downtime. The laser features a nonablative 1470nm wavelength to deliver between 100µ and 700µ of coagulation to the epidermis and dermis, and a 2940nm wavelength to deliver 0µ to 100µ of ablation to the epidermis of the skin. The operator can choose one of three coverage-based treatment levels, and Halo calculates the exact amount of energy necessary to complete an effective treatment. “Hybrid fractional lasers are the next logical evolution in fractional resurfacing,” says plastic surgeon Jason Pozner, MD, FACS. “With Halo, I can achieve results which I would have only expected from an ablative fractional laser, but get downtimes that I would normally see with a nonablative fractional laser. It really is the best of both worlds.” Contact: 888.646.6999, www.halobysciton.com.
